HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS

  • Authors:
    • N ZILEMBO
    • E BAJETTA
    • C NOBERASCO
    • G VICARIO
    • E BICHISAO
    • M D' APRILE
  • View Affiliations

  • Published online on: July 1, 1995     https://doi.org/10.3892/or.2.4.601
  • Pages: 601-602
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The incidence of stage IV breast cancer at diagnosis is low, representing about 8% of all new cases. We report on the results obtained with a new aromatase inhibitor, formestane (500 mg i.m. fortnightly), given as a first treatment to fifteen postmenopausal patients with metastatic breast cancer. The overall response rate was 40%, with one complete remission in a patient with soft tissue and bone lesions and five partial remissions. The drug was well. tolerated and no significant systemic or local side effects were observed. We conclude that first treatment of stage IV breast cancer appears to be feasible with a hormonal drug such as formestane.

Related Articles

Journal Cover

July 1995
Volume 2 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
ZILEMBO N, BAJETTA E, NOBERASCO C, VICARIO G, BICHISAO E and D' APRILE M: HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS. Oncol Rep 2: 601-602, 1995.
APA
ZILEMBO, N., BAJETTA, E., NOBERASCO, C., VICARIO, G., BICHISAO, E., & D' APRILE, M. (1995). HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS. Oncology Reports, 2, 601-602. https://doi.org/10.3892/or.2.4.601
MLA
ZILEMBO, N., BAJETTA, E., NOBERASCO, C., VICARIO, G., BICHISAO, E., D' APRILE, M."HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS". Oncology Reports 2.4 (1995): 601-602.
Chicago
ZILEMBO, N., BAJETTA, E., NOBERASCO, C., VICARIO, G., BICHISAO, E., D' APRILE, M."HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS". Oncology Reports 2, no. 4 (1995): 601-602. https://doi.org/10.3892/or.2.4.601